Literature DB >> 16079872

Calculated resistance in cancer.

Charles L Sawyers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16079872     DOI： 10.1038/nm0805-824

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  6 in total

1.  An elementary approach to modeling drug resistance in cancer.

Authors:  Cristian Tomasetti; Doron Levy
Journal:  Math Biosci Eng       Date:  2010-10       Impact factor: 2.080

2.  Crosstalk between Aurora-A and p53: frequent deletion or downregulation of Aurora-A in tumors from p53 null mice.

Authors:  Jian-Hua Mao; Di Wu; Jesus Perez-Losada; Tao Jiang; Qian Li; Richard M Neve; Joe W Gray; Wei-Wen Cai; Allan Balmain
Journal:  Cancer Cell       Date:  2007-02       Impact factor: 31.743

3.  Error-prone translesion synthesis mediates acquired chemoresistance.

Authors:  Kun Xie; Jason Doles; Michael T Hemann; Graham C Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-10       Impact factor: 11.205

4.  An increase in cell number at completion of therapy may develop as an indicator of early relapse: quantification of circulating epithelial tumor cells (CETC) for monitoring of adjuvant therapy in breast cancer.

Authors:  Katharina Pachmann; Robert Dengler; Kurt Lobodasch; Frank Fröhlich; Torsten Kroll; Matthias Rengsberger; Rene Schubert; Ulrich Pachmann
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-05       Impact factor: 4.553

5.  Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.

Authors:  Jeffrey C Lee; Igor Vivanco; Rameen Beroukhim; Julie H Y Huang; Whei L Feng; Ralph M DeBiasi; Koji Yoshimoto; Jennifer C King; Phioanh Nghiemphu; Yuki Yuza; Qing Xu; Heidi Greulich; Roman K Thomas; J Guillermo Paez; Timothy C Peck; David J Linhart; Karen A Glatt; Gad Getz; Robert Onofrio; Liuda Ziaugra; Ross L Levine; Stacey Gabriel; Tomohiro Kawaguchi; Keith O'Neill; Haumith Khan; Linda M Liau; Stanley F Nelson; P Nagesh Rao; Paul Mischel; Russell O Pieper; Tim Cloughesy; Daniel J Leahy; William R Sellers; Charles L Sawyers; Matthew Meyerson; Ingo K Mellinghoff
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

Review 6.  The treatment landscape of metastatic prostate cancer.

Authors:  Yasutaka Yamada; Himisha Beltran
Journal:  Cancer Lett       Date:  2021-06-18       Impact factor: 8.679
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.